Molecular Basis of Langerhans and Non-Langerhans Cell Histiocytic Neoplasms and Castleman Disease

Clinical trial NCT05028621 · SUSPENDED

Trial details

NCT number: NCT05028621
Sponsor: Case Comprehensive Cancer Center
Status: SUSPENDED
Phase: Not Applicable
Study type: INTERVENTIONAL

Castleman's Disease (CD)Langerhans Cell Histiocytosis (LCH)Non-Langerhans-Cell Histiocytosis

Start date: 2021-06-18
Primary completion: 2026-09-01
Enrollment: 135

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.